News

uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc. The cell & gene therapy (CGT) CDMO...

Croda Pharma and BSI announced that they have entered into a strategic collaboration agreement to support the sustainable sourcing of pharmaceutical grade adjuvant QS-21, a potent component of adjuvant systems. QS-21 is used in several innovative vaccines against diseases such...

Powder transfer specialist, ChargePoint Technology has joined forces with sampling device specialist, Famat Sampling, to tackle one of the industry’s most challenging containment problems. The pharmaceutical suppliers have created an integrated valve solution capable of allowing operators to take...

Lower valuations can benefit acquirers in 2023, but IPOs and venture funding are expected to be slow. To address valuation challenges, the biopharma sector must prioritize clinical successes this year, particularly in areas such as respiratory syncytial virus, Alzheimer's...

Hospitals are in desperate search of a drug that can reverse lead poisoning and a sterile fluid required for heart-stopping during bypass surgery. Shortages of certain antibiotics persist following the winter flu season, leaving doctors and patients scrambling for...

This is a fact: visibility when it comes to the worldwide supply chain happens to be of paramount importance. But there is another fact: the sheer volume and complexity of the data that is involved in global commerce can...

Global pharmaceutical companies have faced significant scrutiny for various issues, such as inconsistent drug availability, a lack of transparency in environmental, social, and governance practices, and a surge in counterfeit medications. This increased scrutiny indicates that the traditional manufacturing...